T helper (Th) 2 cells play a central role in the pathogenesis of allergic diseases such as allergic
asthma,
atopic dermatitis, and
allergic rhinitis. We have found that
YM-341619 hydrochloride, which suppressed IL-4-induced STAT6-dependent reporter gene expression, inhibited the differentiation of mouse spleen T cells into Th2 cells in vitro.
YM-341619 suppressed the production of
IL-4 and the expression of GATA-3
mRNA, a Th2
transcription factor, in T cells cultured with anti-CD3 antibody and anti-CD28 antibody in the presence of
IL-4. In contrast, the production of IFN-gamma and the expression of T-bet
mRNA, a Th1
transcription factor, in T cells cultured with anti-CD3 antibody in the presence of
IL-12, were not effected by
YM-341619. Orally administered
YM-341619 (0.003-0.03 mg/kg) reduced the plasma
IgE level of DNP-Ascaris-sensitized rats, but not the
IgG(2a) level.
YM-341619 suppressed
IL-4 and
IL-13 production in the splenocytes of these DNP-Ascaris-sensitized rats without augmenting IFN-gamma production.
YM-341619 also dose-dependently suppressed eosinophil accumulation in the lung (0.003-3 mg/kg, p.o.) and
airway hyperresponsiveness (0.3-3 mg/kg, p.o.) induced by repeated exposure to
ovalbumin in
ovalbumin-sensitized rats. These results suggest that
YM-341619 has the ability to suppress
allergen-induced Th2 responses by selectively inhibiting the differentiation of CD4(+) T cells into the Th2 subset.